Haralampos M Moutsopoulos
Overview
Explore the profile of Haralampos M Moutsopoulos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
197
Citations
4466
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chatzis L, Goules A, Baldini C, Pezoulas V, Venetsanopoulou A, Voulgari P, et al.
Clin Exp Rheumatol
. 2024 Dec;
42(12):2507-2512.
PMID: 39661569
Objectives: To assess if isolated mouth or eye dryness constitutes distinct clinical phenotypes in Sjögren's disease (SjD). Methods: We analysed 1765 patients meeting the 2016 ACR-EULAR SjD criteria, followed up...
2.
Koulouri V, Bakasis A, Marketos N, Tavernaraki K, Giannelou M, Moutsopoulos H, et al.
J Transl Autoimmun
. 2023 Jan;
6:100183.
PMID: 36619654
Systemic sclerosis (SSc) has been classically linked to interstitial lung disease (ILD) development, often in association with specific SSc autoantibodies. In the present report, we aimed to estimate the prevalence...
3.
Bakasis A, Mavragani C, Voulgari P, Gerolymatou N, Argyropoulou O, Vlachoyiannopoulos P, et al.
J Autoimmun
. 2022 Jun;
131:102846.
PMID: 35717727
Clinical data on vaccinated patients with coronavirus disease 2019 (COVID-19) who have systemic autoimmune and autoinflammatory rheumatic diseases (SAARD) are limited. This observational study aimed to report the clinical features...
4.
Kintrilis N, Gravani F, Rapti A, Papaioannou M, Flessa C, Nezos A, et al.
Rheumatology (Oxford)
. 2022 Jun;
62(2):958-968.
PMID: 35689637
Objectives: RA and primary SS carry increased atherosclerotic risk, while B-cell activating factor holds a vital role in disease pathogenesis and atherosclerosis. We aimed to compare subclinical atherosclerosis profiles between...
5.
Boutzios G, Koukoulioti E, Goules A, Kalliakmanis I, Giovannopoulos I, Vlachoyiannopoulos P, et al.
Front Endocrinol (Lausanne)
. 2022 May;
13:860880.
PMID: 35528009
Background: Hashimoto thyroiditis (HT) is an autoimmune disease which may result in extensive damage of the thyroid gland. Chronic atrophic gastritis (CAG), is the most frequent HT-associated disorder, with anti-parietal...
6.
Flessa C, Zampeli E, Evangelopoulos M, Natsis V, Bodewes I, Huijser E, et al.
Front Immunol
. 2022 Apr;
13:836824.
PMID: 35371038
Background/purpose: Primary Sjögren's Syndrome (SS) is characterized by B lymphocyte hyperactivity with B cell activating factor (BAFF) acting as an important regulator. Single Nucleotide Polymorphisms (SNPs) of the gene have...
7.
Moutsopoulos H
J Transl Autoimmun
. 2022 Jan;
4:100129.
PMID: 35005593
Until the etiopathogenic factor(s) of autoimmune and autoinflammatory rheumatic disorders will be identified, their classification into entities will continue. However, their similar clinical manifestations, overlapping syndromes, evolution from one entity...
8.
Bakasis A, Moutsopoulos H
Mediterr J Rheumatol
. 2021 Dec;
32(3):188-191.
PMID: 34964022
No abstract available.
9.
Zampeli E, Venetsanopoulou A, Christaki S, Argyropoulou O, Boki K, Manoussakis M, et al.
Clin Exp Rheumatol
. 2021 Nov;
40(9):1642-1649.
PMID: 34796838
Objectives: Retroperitoneal fibrosis (RPF) is mostly idiopathic (iRPF); however, it can be secondary to drugs, malignancies, infections, or, as recently recognised, can be part of the IgG4-related diseases. The aim...
10.
Tzioufas A, Bakasis A, Goules A, Bitzogli K, Cinoku I, Chatzis L, et al.
J Autoimmun
. 2021 Nov;
125:102743.
PMID: 34757289
Objectives: To investigate humoral responses and safety of mRNA SARS-CoV-2 vaccines in systemic autoimmune and autoinflammatory rheumatic disease (SAARD) patients subjected or not to treatment modifications during vaccination. Methods: A...